Fels, P.W.

patient argatroban study heparin randomized study infarction timi grade 2 dose -®nding study randomized level 3 ¯ ow group 100 mgakg bolus infusion grade thrombin hospital aptt levels p ˆ ns inhibitor university alteplase -®nding therapy treatment 3 mgakgamin infusion ef ®cacy mgakg thrombin inhibitor 72 hours argami circulation mgakgamin plasma reocclusion effect adjunctive treatment 24 hours complication ngaml heparin group thrombolytic therapy angiography minute vermeer university hospital trial university hospital maastricht thrombolytic result hirudin scienti ®c sessions 1 patient value netherland table hopital safety adjunctive investigator artery dose level center ®cacy patency angina ziekenhui simoon streptokinase aptt values 10 days plasma levels adjunctive therapy baseline reocclusion rates 90 minutes figure dosage regimen tiro ®ban